What CUBIST PHARMACEUTICALS INC's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Corrigan Mark | Director | Jan 21 | Other Transaction · J | −7,501 | $102.00 | −$765K | 0 |
| DesRosier Thomas | EVP, Chief Legal | Jan 21 | Other Transaction · J | −479 | $102.00 | −$48.9K | 0 |
| DesRosier Thomas | EVP, Chief Legal | Jan 21 | Other Transaction · J | −7,967 | $102.00 | −$813K | 0 |
| Moulder Leon O Jr | Director | Jan 21 | Other Transaction · J | −11,101 | $102.00 | −$1.13M | 0 |
| Bonney Michael W | Chief Executive Officer | Jan 21 | Other Transaction · J | −600 | $102.00 | −$61.2K | 0 |
| Bonney Michael W | Chief Executive Officer | Jan 21 | Other Transaction · J | −6,816 | $102.00 | −$695K | 0 |
| Bonney Michael W | Chief Executive Officer | Jan 21 | Other Transaction · J | −176,226 | $102.00 | −$18M | 0 |
| Lawton Alison Francis | Director | Jan 21 | Other Transaction · J | −4,717 | $102.00 | −$481K | 0 |
| Perez Robert J | Chief Executive Officer | Jan 21 | Other Transaction · J | −5,012 | $102.00 | −$511K | 0 |
| Perez Robert J | Chief Executive Officer | Jan 21 | Other Transaction · J | −47,325 | $102.00 | −$4.83M | 0 |
| Vink Patrick V.j.j. | EVP and COO | Jan 21 | Other Transaction · J | −5,496 | $102.00 | −$561K | 0 |
| Tomsicek Michael John | SVP & Chief Financial Officer | Jan 21 | Other Transaction · J | −1,199 | $102.00 | −$122K | 0 |
| Tomsicek Michael John | SVP & Chief Financial Officer | Jan 21 | Other Transaction · J | −14,765 | $102.00 | −$1.51M | 0 |
| Gilman Steven C | EVP & Chief Scientific Officer | Jan 21 | Other Transaction · J | −2,851 | $102.00 | −$291K | 0 |
| Gilman Steven C | EVP & Chief Scientific Officer | Jan 21 | Other Transaction · J | −27,680 | $102.00 | −$2.82M | 0 |
| Bate Kenneth | Director | Jan 21 | Other Transaction · J | −9,615 | $102.00 | −$981K | 0 |
| Henney Jane E Md | Director | Jan 21 | Other Transaction · J | −4,644 | $102.00 | −$474K | 0 |
| Hutson Nancy J | Director | Jan 21 | Other Transaction · J | −5,951 | $102.00 | −$607K | 0 |
| Soeters Martinus Hermanus | Director | Jan 21 | Other Transaction · J | −10,397 | $102.00 | −$1.06M | 0 |
| DesRosier Thomas | EVP, Chief Legal | Dec 31 | Other Transaction · J | +148 | $59.96 | +$8.87K | 7,967 |
Loading...
